Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Lilly’s BTK drug Jaypirca enters first-line CLL
Despite a positive first-line readout, Lilly’s Jake Van Naarden has maintained that the primary use of Jaypirca “remains in second line.”
Angus Liu
Oct 2, 2026 4:15pm
Bayer doubles down on US with $2.2B Ohio manufacturing project
Oct 2, 2026 3:10pm
Hiring for Resilience in Life Sciences Sales
Brought to you by
Mix Talent
Litfulo and tilrekimig data bolster Pfizer's immunology plans
Oct 2, 2026 11:15am
Clinical trials reach a new automation inflection point
Brought to you by
IQVIA
Locking in on pharma’s consumerization trend
Oct 2, 2026 10:36am
